Individuals on blood thinner could also take vaccine: ICMR

▴ Individuals on blood thinner could also take vaccine: ICMR
Doctors confirm use of blood thinners is not a big concern in people lined up for vaccination

Using blood thinners may not be a possible risk factor for coronavirus vaccines and the government is considering allowing companies to drop it as a contraindication from the product fact-sheet, top officials said on Thursday.

“The relative contraindication regarding the blood thinners is mentioned in the fact-sheet of both the vaccines and both the companies have written to the drugs controller general of India (DCGI) regarding changing this point in the fact-sheet,” said Dr Balram Bhargava, director general, Indian Council of Medical Research (ICMR).

“Blood thinners are of two categories- one is antiplatelets that are aspirin, or Clopidogrel and these are not a problem at all; the second is anticoagulants which are drugs like heparin etc. and those patients on these drugs have a much higher tendency to bleed. The only worry is that there can be a local haematoma (blood clot) or local swelling can occur where the injection site is. It is a very relative contraindication,” he said.

The fact-sheets put out by both the Covid-19 vaccine manufacturers had listed use of blood thinners as one of the contraindications for use of Covid-19 vaccine, which experts believe could have led to a huge chunk of Indians choosing to avoid getting the shots. A family of drugs that fall loosely under the umbrella are widely in use in the country due to rising numbers of people with cardiovascular diseases.

“The anticoagulant can be stopped for one or two days prior to giving the vaccine for those on this drug. For other blood thinners like aspirin or Clopidogrel, there are no contraindications, and that will be corrected and rectified in the fact-sheet as soon as the drugs control gives permission for the same,” Dr Bhargava explained.

India has set a target of vaccinating an estimated 300 million high risk population by August. In the first phase, 20 million health care and frontline workers will be vaccinated. Covid-19 vaccination drive began on January 16 in the country with health care workers getting vaccinated.

Doctors say use of blood thinners is not a big concern in people lined up for vaccination. “It is like the annual flu shot, and people on blood thinners also take the flu shot. This is not a major concern,” said Dr GC Khilnani, former, head of pulmonology and sleep medicine department, All India Institute of Medical Science, Delhi.

“As on today 9,000 vaccination sessions are held across the country in a day, which had started with 3,374 on the day of the launch. We track number of sessions scheduled, conducted and beneficiaries vaccinated. And what is the target and what has been the success rate,” said Rajesh Bhushan, secretary, Union health and family welfare ministry.

Story Source: https://www.hindustantimes.com/india-news/vaccine-safe-for-people-on-blood-thinners-icmr-101611857471941.html 

Tags : #ICMR #BloodThinner #AIIMSDelhi #LatestNewsonCOVIDVaccine29thJan #LatestPharmaNews29thJan

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Pervez Musharraf President of Pakistan died of Amyloidosis, a rare diseaseFebruary 07, 2023
National AIDS Control Program – Importance of knowing HIV statusFebruary 06, 2023
FGM : Let's End the practice that hurts girls and womenFebruary 06, 2023
World Cancer Day - Most prominent cancers of IndiaFebruary 04, 2023
World Cancer Day - Never Give up the HopeFebruary 04, 2023
Salt - Effects of Consuming too much SaltFebruary 03, 2023
India’s mission of eliminating dog-mediated rabies by 2030February 03, 2023
Climate change and healthFebruary 02, 2023
Rheumatoid Arthritis Awareness Day: Let's Create AwarenessFebruary 02, 2023
Importance of early diagnosis and cancer screeningFebruary 01, 2023
Union Budget 2023-2024: What's for Healthcare?February 01, 2023
Nourish You has raised $2million to Invest in R&D and Strengthen its Market Presence.February 01, 2023
Enzene Biosciences has raised $50million to expand in its core market of India and US.January 31, 2023
Enzene Biosciences has raised $50million to expand in its core market of India and US.January 31, 2023
World Leprosy Day 2023 – Act now, End LeprosyJanuary 30, 2023
The Warrior Expedition 32/26: A Mission to Encourage Youths to join Indian ForcesJanuary 30, 2023
Mental health – What’s normal and what’s abnormalJanuary 30, 2023
Big Data in Healthcare and Its BenefitsJanuary 27, 2023
Patient Advocacy - The voice of patientJanuary 27, 2023
Republic Day - Vision of Healthy IndiaJanuary 25, 2023